Biospring Partners is a growth-stage investment firm focused on life sciences technology. They target B2B services, tools, and enterprise software companies driving innovation across the life sciences industry. Their investments typically span Series A to Series C rounds, with a particular emphasis on Series A funding.

The firm's portfolio includes notable companies such as ixlayer, Labviva, and PathAI. Biospring leverages its deep experience in life sciences and technology to support portfolio companies, providing valuable industry insights and connections. Their investment philosophy centers on identifying and nurturing innovative technologies that have the potential to transform the life sciences sector.